机器学习在心脏复苏治疗早期推荐中的应用
Application of Machine Learning in Early Recommendation of Cardiac Resynchronization Therapy
摘要:
心力衰竭(HF)是发病率、死亡率和医疗保健费用的主要原因。HF可能会导致心肌传导延长,器械驱动的方法(称为心脏起搏治疗(CRT))可以改善左心室(LV)心肌传导模式。虽然CRT的功能获益已得到证实,但接受CRT的大部分HF患者(30-50%)并未显示出充分的改善。此外,确定HF患者将受益于CRT前瞻性仍然是一个临床挑战。因此,有效预测心脏再同步治疗对心脏功能有益的心力衰竭患者的策略具有重要的医学和社会经济意义。因此,我们使用机器学习方法对HF患者进行分类,即聚类分析、决策树和人工神经网络,以开发CRT后个体结局的预测模型。在心脏再同步治疗前后收集心力衰竭患者的临床、功能和生物标志物数据。将LV容积减少的前瞻性6个月终点定义为CRT应答。使用这种方法(418名应答者,412名无应答者),每个有56个参数,我们可以根据他们对CRT的应答对HF患者进行分类,成功率超过95%。我们已经证明,使用机器学习方法可以识别具有高概率CRT阳性反应(95%准确度)的HF患者,同样重要的是,识别不会从CRT中获得功能获益的HF患者。将该方法开发为临床算法,以协助HF患者使用CRT的临床决策,可能会改善结局并降低医疗保健成本。
英文摘要:
Heart failure (HF) is a leading cause of morbidity, mortality, and health care costs. Prolonged conduction through the myocardium can occur with HF, and a device-driven approach, termed cardiac resynchronization therapy (CRT), can improve left ventricular (LV) myocardial conduction patterns. While a functional benefit of CRT has been demonstrated, a large proportion of HF patients (30-50%) receiving CRT do not show sufficient improvement. Moreover, identifying HF patients that would benefit from CRT prospectively remains a clinical challenge. Accordingly, strategies to effectively predict those HF patients that would derive a functional benefit from CRT holds great medical and socio-economic importance. Thus, we used machine learning methods of classifying HF patients, namely Cluster Analysis, Decision Trees, and Artificial neural networks, to develop predictive models of individual outcomes following CRT. Clinical, functional, and biomarker data were collected in HF patients before and following CRT. A prospective 6-month endpoint of a reduction in LV volume was defined as a CRT response. Using this approach (418 responders, 412 non-responders), each with 56 parameters, we could classify HF patients based on their response to CRT with more than 95% success. We have demonstrated that using machine learning approaches can identify HF patients with a high probability of a positive CRT response (95% accuracy), and of equal importance, identify those HF patients that would not derive a functional benefit from CRT. Developing this approach into a clinical algorithm to assist in clinical decision-making regarding the use of CRT in HF patients would potentially improve outcomes and reduce health care costs.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。